Angel Pang

1.7k total citations
16 papers, 464 citations indexed

About

Angel Pang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Angel Pang has authored 16 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Angel Pang's work include Inhalation and Respiratory Drug Delivery (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Angel Pang is often cited by papers focused on Inhalation and Respiratory Drug Delivery (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Angel Pang collaborates with scholars based in Australia, United States and Canada. Angel Pang's co-authors include Warwick J. Britton, Hak‐Kim Chan, Jeff Holst, Michelle van Geldermalsen, Qian Wang, Yi Fang Guan, L. Jill McCutcheon, Thaigarajan Parumasivam, M. O'Grady and Peter J. O’Brien and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Angel Pang

16 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angel Pang Australia 12 235 108 105 72 68 16 464
Archie Thurston United States 12 166 0.7× 60 0.6× 29 0.3× 62 0.9× 16 0.2× 18 496
Bob Thong United Kingdom 11 154 0.7× 83 0.8× 39 0.4× 4 0.1× 18 0.3× 12 516
Daniel Conole United Kingdom 17 498 2.1× 79 0.7× 24 0.2× 14 0.2× 7 0.1× 34 752
Hao Wen China 12 179 0.8× 40 0.4× 22 0.2× 16 0.2× 11 0.2× 49 403
Steve R. Hood United Kingdom 13 196 0.8× 12 0.1× 30 0.3× 16 0.2× 8 0.1× 35 442
Qiongming Xu China 9 254 1.1× 21 0.2× 61 0.6× 18 0.3× 3 0.0× 10 424
Chikara Shinohara Japan 15 273 1.2× 12 0.1× 57 0.5× 9 0.1× 24 0.4× 18 543
Michał Kiełbik Poland 13 232 1.0× 23 0.2× 81 0.8× 4 0.1× 18 0.3× 29 515

Countries citing papers authored by Angel Pang

Since Specialization
Citations

This map shows the geographic impact of Angel Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel Pang more than expected).

Fields of papers citing papers by Angel Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel Pang. The network helps show where Angel Pang may publish in the future.

Co-authorship network of co-authors of Angel Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Angel Pang. A scholar is included among the top collaborators of Angel Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel Pang. Angel Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Qian, Lake‐Ee Quek, Angel Pang, et al.. (2024). Macropinocytosis mediates resistance to loss of glutamine transport in triple-negative breast cancer. The EMBO Journal. 43(23). 5857–5882. 5 indexed citations
2.
Quek, Lake‐Ee, Michelle van Geldermalsen, Yi Fang Guan, et al.. (2022). Glutamine addiction promotes glucose oxidation in triple-negative breast cancer. Oncogene. 41(34). 4066–4078. 32 indexed citations
3.
Wang, Qian, Yi Fang Guan, Sarah E. Hancock, et al.. (2021). Inhibition of guanosine monophosphate synthetase ( GMPS ) blocks glutamine metabolism and prostate cancer growth. The Journal of Pathology. 254(2). 135–146. 27 indexed citations
4.
Mandigo, Amy C., Christopher McNair, Angel Pang, et al.. (2020). Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer.. Journal of Clinical Oncology. 38(6_suppl). 189–189. 1 indexed citations
5.
Abdelghany, Sharif, Thaigarajan Parumasivam, Angel Pang, et al.. (2019). Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis. Journal of Drug Delivery Science and Technology. 52. 642–651. 57 indexed citations
6.
Geldermalsen, Michelle van, Lake‐Ee Quek, Nigel Turner, et al.. (2018). Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways. BMC Cancer. 18(1). 689–689. 56 indexed citations
7.
Pang, Angel, Tamim Mosaiab, Warwick J. Britton, et al.. (2018). Thioamide Derivative of the Potent Antitubercular 2-(Decylsulfonyl)acetamide is Less Active Against Mycobacterium tuberculosis, but a More Potent Antistaphylococcal Agent. Australian Journal of Chemistry. 71(9). 716–719. 8 indexed citations
8.
Tran, Anh, Emma E. Watson, Venugopal Pujari, et al.. (2017). Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis. Nature Communications. 8(1). 14414–14414. 40 indexed citations
9.
Marshall, Amy D., Michelle van Geldermalsen, Nicholas Otte, et al.. (2017). ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis. 6(7). e367–e367. 63 indexed citations
10.
Parumasivam, Thaigarajan, John Gar Yan Chan, Angel Pang, et al.. (2016). In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment. European Journal of Pharmaceutics and Biopharmaceutics. 107. 205–214. 12 indexed citations
11.
Parumasivam, Thaigarajan, John Gar Yan Chan, Angel Pang, et al.. (2016). In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy. Molecular Pharmaceutics. 13(3). 979–989. 17 indexed citations
12.
Chan, John Gar Yan, Angel Pang, Andrew J. McLachlan, et al.. (2014). Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder. International Journal of Antimicrobial Agents. 45(3). 319–323. 13 indexed citations
13.
Chan, John Gar Yan, Angel Pang, Hak‐Kim Chan, et al.. (2013). A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection. Pharmaceutical Research. 31(5). 1239–1253. 39 indexed citations
14.
Giltrap, Andrew M., Katie M. Cergol, Angel Pang, Warwick J. Britton, & Richard J. Payne. (2013). Total Synthesis of Fellutamide B and Deoxy-Fellutamides B, C, and D. Marine Drugs. 11(7). 2382–2397. 11 indexed citations
15.
Cergol, Katie M., Noeris K. Salam, Esther M. M. Bulloch, et al.. (2012). Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site. Organic & Biomolecular Chemistry. 10(46). 9223–9223. 20 indexed citations
16.
McCutcheon, L. Jill, et al.. (1993). Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 264(3). H926–H937. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026